Related Experiment Video
Updated: Mar 14, 2026
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Per Migliorare la Guarigione di Pazienti Affetti da Infezione del Tratto Respiratorio
Abstract:
The common respiratory tract infections of acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and community-acquired pneumonia are responsible for millions of physician office visits every year. Despite advances in diagnostic testing and the development of new antimicrobial agents, these infections continue to contribute significantly to patient morbidity and mortality worldwide. Physicians are faced with multiple challenges in the management of patients with these diseases. These challenges include the selection of appropriate empiric therapy, the increasing emergence of resistant pathogens, patient noncompliance with therapeutic regimens, and the pressure to use costeffective agents. Patients expect their antibiotics to work rapidly so that they can feel better quickly and return swiftly to their normal activities. Moxifloxacin has been developed to address many of these problems. Its efficacy has been demonstrated in an extensive clinical trial program the results of which are summarized below. The excellent pharmacokinetics and pharmacodynamics of moxifloxacin are covered elsewhere in this supplement, as is moxifloxacin's impressive safety and tolerability profile. Accordingly, this paper focuses on the clinical trial data currently available.
Insights
Moxifloxacin effectively treats common respiratory infections like sinusitis and pneumonia. Clinical trials show its efficacy in managing these widespread bacterial infections, addressing physician and patient needs.
Area of Science:
- Infectious Diseases
- Pharmacology
- Respiratory Medicine
Background:
- Acute bacterial sinusitis, chronic bronchitis exacerbations, and community-acquired pneumonia cause millions of physician visits annually.
- These infections contribute significantly to global morbidity and mortality despite diagnostic and antimicrobial advances.
- Physicians face challenges in managing these infections, including empiric therapy selection, pathogen resistance, and cost-effectiveness.
Purpose of the Study:
- To present clinical trial data for moxifloxacin.
- To highlight moxifloxacin's efficacy in treating common respiratory tract infections.
- To address challenges in managing bacterial respiratory infections.
Main Methods:
- Extensive clinical trial program.
- Focus on available clinical trial data for moxifloxacin.
- Evaluation of efficacy in treating acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and community-acquired pneumonia.
Main Results:
- Moxifloxacin demonstrated efficacy in clinical trials.
- The drug addresses key challenges in treating common respiratory infections.
- Clinical data supports moxifloxacin's role in patient management.
Conclusions:
- Moxifloxacin is an effective treatment option for common respiratory tract infections.
- The drug's efficacy has been established through a comprehensive clinical trial program.
- Moxifloxacin offers a solution to several management challenges faced by physicians.
Related Concept Videos
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:17Pulmonary Cycle: Exhalation
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...